tosufloxacin has been researched along with Prostatic Hyperplasia in 3 studies
tosufloxacin: quinolone anti-infective agent; structure given in first source
tosufloxacin : A racemate comprising equimolar amounts of (R)- and (S)-tosufloxacin.
7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid : A 1,8-naphthyridine derivative that is 4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid bearing additional 2,4-difluorophenyl, fluoro and 3-aminopyrrolidin-1-yl substituents at positions 1, 6 and 7 respectively.
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsuji, Y | 1 |
| Okamura, K | 1 |
| Miyake, K | 1 |
| Ito, H | 1 |
| Kinukawa, T | 1 |
| Otani, T | 1 |
| Narushima, M | 1 |
| Kanai, S | 1 |
| Takagi, Y | 1 |
| Murase, T | 1 |
| Yoshida, O | 1 |
| Arai, Y | 1 |
| Takeuchi, H | 1 |
| Fukuyama, T | 1 |
| Hida, S | 1 |
| Ikeda, T | 1 |
| Okabe, T | 1 |
| Kuo, SY | 1 |
| Kounami, T | 1 |
| Nakagawa, T | 1 |
| Uchibayashi, T | 1 |
| Hisazumi, H | 1 |
| Kanayama, J | 1 |
| Kumano, K | 1 |
2 trials available for tosufloxacin and Prostatic Hyperplasia
| Article | Year |
|---|---|
[Antibiotic prophylaxis for transurethral resection of the prostate--comparison of oral administration therapy with intravenous administration therapy].
Topics: Administration, Oral; Aged; Anti-Infective Agents; Cefotiam; Fever; Fluoroquinolones; Humans; Inject | 1993 |
[Preventive chemotherapy after transurethral prostatectomy: a randomized study].
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Drug Administration Schedule; Fluoroquinolones; Huma | 1993 |
1 other study available for tosufloxacin and Prostatic Hyperplasia
| Article | Year |
|---|---|
Diffusion of tosufloxacin into prostatic tissue.
Topics: 4-Quinolones; Administration, Oral; Aged; Aged, 80 and over; Anti-Infective Agents; Fluoroquinolones | 1992 |